Pharmaceutical Pellets Market Size, Share, Trends, Growth 2032

Pharmaceutical Pellets Industry Prospective:

The global pharmaceutical pellets market size was evaluated at $18.26 billion in 2023 and is slated to hit $49.33 billion by the end of 2032 with a CAGR of nearly 11.68% between 2024 and 2032.  

Request Free Sample

Pharmaceutical Pellets Market: Overview

Pharmaceutical pellets are referred to as multi-particulate doses that are made through a combination of mediations with finely ground excipients for producing small, spherical, semi-spherical, and spherical particles. Furthermore, it is utilized for producing medication doses that are formed with prolonged release. Key techniques involved in pharmaceutical pellets are suspension learning, spray drying, and spray congealing.

Key Insights

• As per the analysis shared by our research analyst, the global pharmaceutical pellets market is projected to expand annually at the annual growth rate of around 11.68% over the forecast timespan (2024-2032)
• In terms of revenue, the global pharmaceutical pellets market size was evaluated at nearly $18.26 billion in 2023 and is expected to reach $49.33 billion by 2032.
• The global pharmaceutical pellets market is anticipated to grow rapidly over the forecast timeline owing to the occurrence of chronic disorders such as cancers, kidney disorders, systemic ailments, and respiratory ailments.
• In terms of technology, the extrusion segment is slated to register the highest CAGR over the forecast period.
• Based on mechanism of action, the diffusion segment is predicted to dominate the segmental space in the years to come.
• Region-wise, the Asia-Pacific pharmaceutical pellets industry is projected to register the fastest CAGR during the projected timespan.

Request Free Sample

Pharmaceutical Pellets Market: Growth Factors

Burgeoning demand for personalized drugs will spur the global market trends over 2024-2032

Escalating demand for precision medicine is predicted to boost the global pharmaceutical pellets market surge over the forecast period. Moreover, the occurrence of chronic disorders such as cancers, kidney disorders, systemic ailments, and respiratory ailments is anticipated to pave the way for the humungous growth of the global market. A prominent increment in the life-threatening disorders including high blood pressure, coronary artery diseases, stroke, and high cholesterol is expected to provide impetus to the expansion of the market across the globe.

Apart from this, the presence of strong healthcare infrastructure facilities in emerging economies and a rise in the acceptance of pharmaceutical pellets by patients will expand the scope of growth of the market across the globe in the coming years.

Pharmaceutical Pellets Market: Restraints

A surge in product costs can hinder the global industry expansion by 2032

A rise in the prices of products can impede the expansion of the global pharmaceutical pellets industry in the ensuing years. Fluctuating raw material costs and supply chain oscillations can prove detrimental to the growth of the industry globally.

Pharmaceutical Pellets Market: Opportunities

A rise in the fund allocation in research to open new growth avenues for the global market

An increase in the investments by government & private players in the research activities of the pharmaceutical sector will prop up the scope of growth of the global pharmaceutical pellets market.

Pharmaceutical Pellets Market: Challenges

Surging manufacturing costs of products can challenge the global industry expansion over forecast timeline

Escalating the costs of producing the drugs can prove to be a huge challenge for the progress of the global pharmaceutical pellets industry. Apart from this, the lack of availability of experts who can effectively handle the drugs can further retard the growth of the global industry in the near future.

Pharmaceutical Pellets Market: Segmentation

The global pharmaceutical pellets market is divided into technology, mechanism of action, and region.                                        

In technology terms, the pharmaceutical pellets market across the globe is segregated into extrusion, spray congealing, fluid bed granulation, dry powder layering, solution & suspension layering, and spray drying segments. Furthermore, the extrusion segment, which accumulated nearly two-thirds of the global market earnings in 2023, is expected to record the highest growth rate in the forecast timeframe. The expansion of the segment in the next eight years can be a result of a rise in the use of extrusion techniques for producing pharmaceutical pellets of uniform size.

On the basis of mechanism of action, the global pharmaceutical pellets industry is bifurcated into diffusion, erosion, and osmosis segments. Additionally, the diffusion segment, which acquired the largest chunk of the global industry share in 2023, is projected to lead the segmental landscape in the next couple of years. The segmental expansion from 2024 to 2032 can be ascribed to the rise in the use of the diffusion mechanism for drug release from pharmaceutical pellets.

Pharmaceutical Pellets Market: Report Scope

Pharmaceutical Pellets Market: Regional Insights

North America is predicted to maintain the leading position in the global pharmaceutical pellets market in the ensuing years

North America, which contributed the highest percentage of the global pharmaceutical pellets market share in 2023, is set to lead the global market size in the years to come. Furthermore, the regional market expansion in the next couple of years can be due to an increment in the R&D activities in the pharmaceutical sector in countries such as Canada and the U.S. Apart from this, the presence of key manufacturers and local vendors in these countries will further proliferate the growth of the regional market.

Asia-Pacific pharmaceutical pellets industry is expected to register the fastest CAGR in the forecast timeline. The elevation of the industry in the APAC region over the coming eight years can be credited to a rise in the aging population in countries of Asia such as India and China. In addition to this, a surge in the allocation of funds by the government for producing pharmaceutical pellets will stimulate the growth of the industry in the region.  Easy access to biopharmaceuticals in the sub-continent will bolster the product demand in the region.  

Key Developments

• In the first quarter of 2023, Concord Drugs Limited, a pharmaceutical firm, modified sustained release pellets, multiple unit pellet system, and expanded release through the use of its advanced manufacturing equipment and new drug delivery systems.
• In the first half of 2023, Colorocon Corporation acquired Airnov Healthcare Packaging, a division of Arsenal Capital Partners. The strategic move will help Colorocon in expanding its health & wellness product portfolio.

Pharmaceutical Pellets Market: Competitive Space

The global pharmaceutical pellets market profiles key players such as:

• Abbott Laboratories
• Nordic Sugar
• Manus Aktteva Biopharma LLP
• Lograns Pharma Private Limited
• MB Sugars & Pharmaceuticals Limited
• Thexa Pharma (P) Limited
• Avanscure Lifesciences Private Limited
• Nanjing Joyfulchem Co. Ltd.
• Nami Pharma
• U.K. Vet Chem.
• Colorcon Inc.
• Concord Drugs Limited
• Centaur Pharmaceuticals Private Limited
• Rainbow Health Care Products
• Chemit Laboratories.

The global pharmaceutical pellets market is segmented as follows:

By Technology

• Extrusion
• Spray Congealing
• Fluid Bed Granulation
•  Dry Powder Layering
• Solution & Suspension Layering
• Spray Drying

By Mechanism of Action

• Diffusion
• Erosion
• Osmosis

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa